Pub Date : 2023-10-01DOI: 10.17712/nsj.2023.4.20230060
Badriah M Alsabbagh, Awn Alessa, Hanan Aljohani, Othman Alhammad
Aneurysmal bone cysts (ABCs) are rare benign vascular bony lesions mostly encountered in young patients. These cysts can occur as primary lesions or, less frequently, secondary to other pathologies such as osteoblastomas. Skull ABCs are rare and can extend intracranially, presenting with hydrocephalus and bleeding. Here we illustrate the case of a 9-year-old male who presented with headache, nausea, and vomiting, without neurological deficit. Radiological investigations showed a soap-bubble lesion with mass effect over the right cerebellum. The patient underwent right sub-occipital craniotomy with marginal wide resection of the cystic lesion. The patient had excellent outcomes. The histopathological report was consistent with osteoblastoma with an aneurysmal bone cyst.
{"title":"Large skull osteoblastoma presented as aneurysmal bone cyst (ABC).","authors":"Badriah M Alsabbagh, Awn Alessa, Hanan Aljohani, Othman Alhammad","doi":"10.17712/nsj.2023.4.20230060","DOIUrl":"10.17712/nsj.2023.4.20230060","url":null,"abstract":"<p><p>Aneurysmal bone cysts (ABCs) are rare benign vascular bony lesions mostly encountered in young patients. These cysts can occur as primary lesions or, less frequently, secondary to other pathologies such as osteoblastomas. Skull ABCs are rare and can extend intracranially, presenting with hydrocephalus and bleeding. Here we illustrate the case of a 9-year-old male who presented with headache, nausea, and vomiting, without neurological deficit. Radiological investigations showed a soap-bubble lesion with mass effect over the right cerebellum. The patient underwent right sub-occipital craniotomy with marginal wide resection of the cystic lesion. The patient had excellent outcomes. The histopathological report was consistent with osteoblastoma with an aneurysmal bone cyst.</p>","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"28 4","pages":"277-280"},"PeriodicalIF":1.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41237261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.17712/nsj.2023.4.20230024
Rahaf F Alkahtani, Mohammad F Alhinti, Maha H AlRashid, Abdulrahman A Alomar, Shawg S Alrumaih, Abdulrahman F Alkanhal, Awad A AlHarbi, Abdulaziz M AlAbdulSalam
Objectives: To measure and assess the physical activity (PA) of patients with multiple sclerosis (MS) and its association with the quality of life (QoL).
Methods: This cross-sectional study included patients with MS in Kingdom of Saudi Arabia from August, 2022 to November, 2022. Data were collected via social media platforms using a questionnaire that included 3 sections: sociodemographic data, International PA Questionnaire (IPAQ), and the Health Status Questionnaire Short Form-36 (SF-36).
Results: In total, 145 eligible patients with MS were included. The patients' ages ranged from 18 to 60 years, with a mean age of 33.2±13.9 years. Females were predominantly affected, and most of the patients were either not working or retired. Relapsing-remitting MS constituted the majority (66.2%) of patients. Additionally, most patients (75.9%) were free from co-morbidities. Approximately 41.7% of patients with high PA levels had good QoL scores.
Conclusion: Higher PA levels was significantly associated with better QoL in patients with MS. High PA can improve the QoL by taking into consideration several factors that could influence readiness for exercise and its effect on MS symptoms.
{"title":"Physical activity assessment among patients with multiple sclerosis in Saudi Arabia.","authors":"Rahaf F Alkahtani, Mohammad F Alhinti, Maha H AlRashid, Abdulrahman A Alomar, Shawg S Alrumaih, Abdulrahman F Alkanhal, Awad A AlHarbi, Abdulaziz M AlAbdulSalam","doi":"10.17712/nsj.2023.4.20230024","DOIUrl":"10.17712/nsj.2023.4.20230024","url":null,"abstract":"<p><strong>Objectives: </strong>To measure and assess the physical activity (PA) of patients with multiple sclerosis (MS) and its association with the quality of life (QoL).</p><p><strong>Methods: </strong>This cross-sectional study included patients with MS in Kingdom of Saudi Arabia from August, 2022 to November, 2022. Data were collected via social media platforms using a questionnaire that included 3 sections: sociodemographic data, International PA Questionnaire (IPAQ), and the Health Status Questionnaire Short Form-36 (SF-36).</p><p><strong>Results: </strong>In total, 145 eligible patients with MS were included. The patients' ages ranged from 18 to 60 years, with a mean age of 33.2±13.9 years. Females were predominantly affected, and most of the patients were either not working or retired. Relapsing-remitting MS constituted the majority (66.2%) of patients. Additionally, most patients (75.9%) were free from co-morbidities. Approximately 41.7% of patients with high PA levels had good QoL scores.</p><p><strong>Conclusion: </strong>Higher PA levels was significantly associated with better QoL in patients with MS. High PA can improve the QoL by taking into consideration several factors that could influence readiness for exercise and its effect on MS symptoms.</p>","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"28 4","pages":"243-249"},"PeriodicalIF":1.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41237262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.17712/nsj.2023.4.20230007
Abrar A Khan, Waleed M Alzahrani, Reem M Bagadood, Baker M Alweshah, Jwana F Alsulaimi, Hanadi M Abualela
Objectives: To evaluate the clinical and electrographic features of patients with autoimmune epilepsy and assess the influence of early diagnosis and treatment on reducing seizure frequency.
Methods: A retrospective observational case series was conducted utilizing medical records from King Abdullah Medical Hospital between 2017 and 2022. Cases of newly diagnosed seizures were chosen based on laboratory-proven autoimmunity.
Results: Five female inpatients were identified, primarily presenting with seizures suggestive of an autoimmune origin. Autoimmune antibodies were detected in all patients as follows: GAD (3), NMDA-R (2). One patient exhibited unilateral temporal lobe onset while three displayed bilateral onset. One patient had an associated malignancy. Rituximab was administered as an immunomodulatory therapy to four patients, resulting in successful seizure reduction post-immunotherapy initiation.
Conclusion: Autoimmune epilepsy is recognized as a distinct condition. The clinical presentation can be complex and antibody testing may warrant repetition if initial results are negative or if specific antibodies are not detected. Early initiation of immunosuppression, coupled with prompt treatment escalation when required, is vital for achieving optimal patient outcomes.
{"title":"Autoimmune epilepsy, retrospective case series of clinical features, management, and outcomes.","authors":"Abrar A Khan, Waleed M Alzahrani, Reem M Bagadood, Baker M Alweshah, Jwana F Alsulaimi, Hanadi M Abualela","doi":"10.17712/nsj.2023.4.20230007","DOIUrl":"10.17712/nsj.2023.4.20230007","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the clinical and electrographic features of patients with autoimmune epilepsy and assess the influence of early diagnosis and treatment on reducing seizure frequency.</p><p><strong>Methods: </strong>A retrospective observational case series was conducted utilizing medical records from King Abdullah Medical Hospital between 2017 and 2022. Cases of newly diagnosed seizures were chosen based on laboratory-proven autoimmunity.</p><p><strong>Results: </strong>Five female inpatients were identified, primarily presenting with seizures suggestive of an autoimmune origin. Autoimmune antibodies were detected in all patients as follows: GAD (3), NMDA-R (2). One patient exhibited unilateral temporal lobe onset while three displayed bilateral onset. One patient had an associated malignancy. Rituximab was administered as an immunomodulatory therapy to four patients, resulting in successful seizure reduction post-immunotherapy initiation.</p><p><strong>Conclusion: </strong>Autoimmune epilepsy is recognized as a distinct condition. The clinical presentation can be complex and antibody testing may warrant repetition if initial results are negative or if specific antibodies are not detected. Early initiation of immunosuppression, coupled with prompt treatment escalation when required, is vital for achieving optimal patient outcomes.</p>","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"28 4","pages":"264-269"},"PeriodicalIF":1.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41237253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Joint statement by UNICEF Executive Director and WHO Director-General on the occasion of World Breastfeeding Week.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"28 4","pages":"286-287"},"PeriodicalIF":0.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41237260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.17712/nsj.2023.4.20230034
Fahad S Alshehri
Complex regional pain syndrome (CRPS) is a chronic disease that affects a limb following an injury or trauma. The CRPS associated with symptoms, including severe pain, swelling, as well as changes in skin color and temperature. Treatment of CRPS requires a multidisciplinary approach, with a focus on personalized treatment plans and addressing psychological factors. This review provides an overview of updates in the diagnosis and treatment of CRPS. There are clinical criteria for diagnosing CRPS, including persistent pain and swelling. The CRPS can also be diagnosed with imaging and laboratory tests. Novel insights into treatment approaches for CRPS have been gained from advances in understanding its pathophysiology. Treatment of CRPS includes both pharmacological and non-pharmacological interventions. The latest guidelines for CRPS treatment emphasize the importance of early diagnosis and intervention, personalized treatment plans, and addressing psychological factors in managing CRPS.
{"title":"The complex regional pain syndrome: Diagnosis and management strategies.","authors":"Fahad S Alshehri","doi":"10.17712/nsj.2023.4.20230034","DOIUrl":"10.17712/nsj.2023.4.20230034","url":null,"abstract":"<p><p>Complex regional pain syndrome (CRPS) is a chronic disease that affects a limb following an injury or trauma. The CRPS associated with symptoms, including severe pain, swelling, as well as changes in skin color and temperature. Treatment of CRPS requires a multidisciplinary approach, with a focus on personalized treatment plans and addressing psychological factors. This review provides an overview of updates in the diagnosis and treatment of CRPS. There are clinical criteria for diagnosing CRPS, including persistent pain and swelling. The CRPS can also be diagnosed with imaging and laboratory tests. Novel insights into treatment approaches for CRPS have been gained from advances in understanding its pathophysiology. Treatment of CRPS includes both pharmacological and non-pharmacological interventions. The latest guidelines for CRPS treatment emphasize the importance of early diagnosis and intervention, personalized treatment plans, and addressing psychological factors in managing CRPS.</p>","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"28 4","pages":"211-219"},"PeriodicalIF":1.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41237266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Afghanistan's health system suffers critical underfunding, calls for donor support.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"28 4","pages":"287-288"},"PeriodicalIF":0.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41237243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.17712/nsj.2023.4.20230030
Muhannad A Asiri, Mohammed S Alqahtani, Saeed A Alqahtani, Mohammed M Alwadai, Naif F Alharbi, Mohammed O Aqeeli, Saeed S Alzahrani
Objectives: To investigate the prevalence and risk factors linked to contrast-induced nephropathy in this specific patient population, aiming to ensure the highest quality of clinical care.
Methods: In a retrospective analysis, all patients who presented with an acute stroke to King Fahad Hospital, Jeddah, Emergency Department from March until November 2022 and underwent Computed Tomography Angiography (CTA) brain, Inclusion criteria were as follows: a baseline creatinine results and CTA examination performed within 24 hours of symptom onset and an available early (<5 days after CTA) follow-up creatinine result.
Results: Among 246 stroke patients in the emergency, 182 underwent brain CTA and 8.24% had Contrast-Induced Nephropathy (CIN). intracerebral hemorrhage (ICH) increased CIN risk 7-fold (OR=6.7; 95% CI: 1.23-33.3). Abnormal baseline raised CIN risk 8-fold (OR=7.8; 95% CI: 1.74-35.1). hypertension doubled the risk for CIN (OR=2.1; 95% CI: 1.26-6.98) CONCLUSION: The incidence of CIN was 8.2%, particularly elevated in patients with ICH, hypertension, tissue plasminogen administration, and abnormal baseline, necessitating vigilance in managing acute stroke cases.
{"title":"Incidence and risk factors of contrast-induced nephropathy in acute stroke patients undergoing computed tomography angiography: A single-center study.","authors":"Muhannad A Asiri, Mohammed S Alqahtani, Saeed A Alqahtani, Mohammed M Alwadai, Naif F Alharbi, Mohammed O Aqeeli, Saeed S Alzahrani","doi":"10.17712/nsj.2023.4.20230030","DOIUrl":"10.17712/nsj.2023.4.20230030","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the prevalence and risk factors linked to contrast-induced nephropathy in this specific patient population, aiming to ensure the highest quality of clinical care.</p><p><strong>Methods: </strong>In a retrospective analysis, all patients who presented with an acute stroke to King Fahad Hospital, Jeddah, Emergency Department from March until November 2022 and underwent Computed Tomography Angiography (CTA) brain, Inclusion criteria were as follows: a baseline creatinine results and CTA examination performed within 24 hours of symptom onset and an available early (<5 days after CTA) follow-up creatinine result.</p><p><strong>Results: </strong>Among 246 stroke patients in the emergency, 182 underwent brain CTA and 8.24% had Contrast-Induced Nephropathy (CIN). intracerebral hemorrhage (ICH) increased CIN risk 7-fold (OR=6.7; 95% CI: 1.23-33.3). Abnormal baseline raised CIN risk 8-fold (OR=7.8; 95% CI: 1.74-35.1). hypertension doubled the risk for CIN (OR=2.1; 95% CI: 1.26-6.98) CONCLUSION: The incidence of CIN was 8.2%, particularly elevated in patients with ICH, hypertension, tissue plasminogen administration, and abnormal baseline, necessitating vigilance in managing acute stroke cases.</p>","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"28 4","pages":"258-263"},"PeriodicalIF":1.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41237259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.17712/nsj.2023.4.20230066
Sounira Mehri, Josef Finsterer, Osama Y Muthaffar
{"title":"Treatment of epileptic drop attacks (atonic seizures) not only depends on skills, but also etiology, tolerability, and EEG.","authors":"Sounira Mehri, Josef Finsterer, Osama Y Muthaffar","doi":"10.17712/nsj.2023.4.20230066","DOIUrl":"10.17712/nsj.2023.4.20230066","url":null,"abstract":"","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"28 4","pages":"281-282"},"PeriodicalIF":1.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827035/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41237268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"How well do face masks worn by children block the release of exhaled particles?","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"28 3","pages":"207"},"PeriodicalIF":0.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3a/64/Neurosciences-28-3-207.PMC10519654.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41207260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-07-01DOI: 10.17712/nsj.2022.3.20220037
K. A. Quliti
Objectives: To explore depression and its associated factors in a sample of primary headache patients with a history of head-neck trauma (Ph-nT). Methods: A cross-sectional study of 120 conveniently sampled patients at Al Madinah Al Munawarah hospitals, Saudi Arabia during the period of June 2019 to December 2019 with Primary headache and history of head-neck trauma completed the depression subscale of the Depression, Anxiety and Stress Scale-21 (DASS-21), and a structured tool for demographics and clinical characteristics. Results: Prevalence of moderate to extremely severe levels of depression was 15.8%. The majority of Ph-nT were female (64.2%), had migraine (with/without aura) (57.5%), recorded no sports-related activities (65.8%), and complained of insufficient sleep (67.5%). Primary headache patients with a history of head-neck trauma, and a family history of migraine/chronic headache, had higher depression scores (β=1.77, p=0.02). Conclusion: Prevalence of depressive symptoms is higher in a sample of primary headache patients with a history of head-neck trauma than in the population that did not experience that trauma. Identification of predictors of depression in primary headache patients with a history of head-neck trauma may help in evolving targeted prevention and screening programs.
目的:探讨有头颈外伤(Ph-nT)史的原发性头痛患者抑郁及其相关因素。方法:对2019年6月至2019年12月在沙特阿拉伯Al Madinah Al Munawarah医院方便抽样的120例原发性头痛和头颈部创伤史患者进行横断面研究,完成抑郁、焦虑和压力量表-21 (das -21)的抑郁亚量表,并使用人口统计学和临床特征的结构化工具。结果:中度至极重度抑郁症患病率为15.8%。大多数Ph-nT是女性(64.2%),有偏头痛(有/没有先兆)(57.5%),没有记录与运动相关的活动(65.8%),抱怨睡眠不足(67.5%)。有头颈外伤史和偏头痛/慢性头痛家族史的原发性头痛患者抑郁评分较高(β=1.77, p=0.02)。结论:有头颈外伤史的原发性头痛患者抑郁症状的患病率高于没有头颈外伤史的人群。确定头颈部创伤史的原发性头痛患者抑郁的预测因素可能有助于制定有针对性的预防和筛查方案。
{"title":"Prevalence of depressive symptoms and its correlates in primary headache patients with a history of head-neck trauma","authors":"K. A. Quliti","doi":"10.17712/nsj.2022.3.20220037","DOIUrl":"https://doi.org/10.17712/nsj.2022.3.20220037","url":null,"abstract":"Objectives: To explore depression and its associated factors in a sample of primary headache patients with a history of head-neck trauma (Ph-nT). Methods: A cross-sectional study of 120 conveniently sampled patients at Al Madinah Al Munawarah hospitals, Saudi Arabia during the period of June 2019 to December 2019 with Primary headache and history of head-neck trauma completed the depression subscale of the Depression, Anxiety and Stress Scale-21 (DASS-21), and a structured tool for demographics and clinical characteristics. Results: Prevalence of moderate to extremely severe levels of depression was 15.8%. The majority of Ph-nT were female (64.2%), had migraine (with/without aura) (57.5%), recorded no sports-related activities (65.8%), and complained of insufficient sleep (67.5%). Primary headache patients with a history of head-neck trauma, and a family history of migraine/chronic headache, had higher depression scores (β=1.77, p=0.02). Conclusion: Prevalence of depressive symptoms is higher in a sample of primary headache patients with a history of head-neck trauma than in the population that did not experience that trauma. Identification of predictors of depression in primary headache patients with a history of head-neck trauma may help in evolving targeted prevention and screening programs.","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"27 1","pages":"181 - 186"},"PeriodicalIF":0.9,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42877913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}